RIVVE Expands GCC Footprint
Press Release - Dec 2025
RIVVE Life Science Expands Across the GCC, Strengthening Its Position as a Leading Pharmaceutical Commercialization Partner
RIVVE Life Science, a GCC-focused pharmaceutical commercialization partner, today announced the expansion of its regional footprint beyond the United Arab Emirates and the Kingdom of Saudi Arabia into the broader Gulf Cooperation Council (GCC). This milestone is supported by newly established partnership agreements across key GCC markets, reinforcing RIVVE’s commitment to enabling global biopharmaceutical companies to access and scale across the region.
Building on its strong presence in the UAE and Saudi Arabia, RIVVE has extended its commercialization platform to encompass additional GCC countries, offering partners a seamless, regionally integrated approach to market entry and expansion.
With comprehensive capabilities spanning regulatory strategy, market access, pricing and reimbursement, and commercial execution, RIVVE delivers end-to-end solutions designed to accelerate product launches and navigate the complex healthcare landscapes across the GCC.
“As the GCC continues to emerge as a strategic growth region for global biopharma, companies increasingly require partners with both regional reach and deep local expertise,” said Mostafa Nagib, Chief Executive Officer of RIVVE Life Science. “Through our expanded footprint and new in-market partnerships, we are uniquely positioned to support seamless, multi-country market entry while ensuring compliance, efficiency, and speed to market.”
RIVVE Life Science operates within a broader regional ecosystem alongside established commercialization companies, including NewBridge Pharmaceuticals, Genpharma and GAIA Healthcare. Through its differentiated and agile model, RIVVE delivers tailored solutions that address the evolving needs of the GCC healthcare landscape while enabling partners to unlock the full potential of the region.
Become Our Partner
About RIVVE Life Science
RIVVE Life Science is a GCC-focused pharmaceutical commercialization partner, providing integrated, end-to-end services across regulatory strategy, market access, and commercial execution. The company’s mission is to enable biopharmaceutical organizations to successfully establish, expand, and sustain their presence across the UAE, Saudi Arabia, and the wider Middle East.